Francois Ghiringhelli
机构：Inserm, Université de Bourgogne, Centre Georges François Leclerc, Université Bourgogne Franche-Comté, Institut Agro Dijon
发表论文 2 篇 · 总被引 1 次 · h-index 1
代表论文
- Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met–Targeting Antibody–Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer (2026 · Clinical Cancer Research · 被引 1)
- Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes (2026 · Journal for ImmunoTherapy of Cancer)